Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Samah Alimam · SciRah

Researcher profile · Semantic Scholar

Samah Alimam

Share profile

Samah Alimam — researcher profile on SciRah

h-index: 11
Works: 45
Citations: 650

Most-cited papers

Molecular MRD status and outcome after transplantation in NPM1 mutated AML: results from the UK NCRI AML17 study.
Richard Dillon, R. Hills, S. Freeman, N. Potter +35 more
2019Blood156 citations Open access
Semantic Scholar
Ruxolitinib versus best available therapy for ET intolerant or resistant to hydroxycarbamide in a randomized trial.
C. Harrison, A. Mead, A. Panchal, Sonia Fox +17 more
2017Blood148 citations Open access
Semantic Scholar
Pregnancy outcomes in myeloproliferative neoplasms: UK prospective cohort study
Samah Alimam, S. Bewley, L. Chappell, M. Knight +4 more
2016British Journal of Haematology85 citations Open access
Semantic Scholar
Machine learning in transfusion medicine: A scoping review
Suzanne Maynard, Joseph Farrington, Samah Alimam, H. Evans +3 more
2023Transfusion45 citations Open access
Semantic Scholar
Risk of venous thromboembolism in pregnant women with essential thrombocythemia: a systematic review and meta-analysis.
L. Skeith, M. Carrier, S. Robinson, Samah Alimam +1 more
2016Blood43 citations Open access
Semantic Scholar
Patients with triple-negative, JAK2V617F- and CALR-mutated essential thrombocythemia share a unique gene expression signature.
Samah Alimam, William Villiers, R. Dillon, M. Simpson +16 more
2021Blood Advances21 citations Open access
Semantic Scholar
How we diagnose and treat essential thrombocythaemia
Samah Alimam, B. Wilkins, Claire N. Harrison
2015British Journal of Haematology20 citations
Semantic Scholar
Altered immune response to the annual influenza A vaccine in patients with myeloproliferative neoplasms
Samah Alimam, Jessica Ann Timms, C. Harrison, R. Dillon +8 more
2020British Journal of Haematology17 citations Open access
Semantic Scholar
The poor outcome in high molecular risk, hydroxycarbamide resistant/intolerant ET is not ameliorated by ruxolitinib
J. O'Sullivan, A. Hamblin, C. Yap, Sonia Fox +10 more
2019Blood16 citations Open access
Semantic Scholar
Experience with ruxolitinib in the treatment of polycythaemia vera
Samah Alimam, C. Harrison
2017Therapeutic Advances in Hematology12 citations Open access
Semantic Scholar
Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide
Claire N. Harrison, Adam J. Mead, A. Panchal, Sonia Fox +17 more
201711 citations
Semantic Scholar
Disease characteristics and outcomes in younger adults with primary and secondary myelofibrosis
Yan Beauverd, Samah Alimam, D. Mclornan, D. Radia +1 more
2016British Journal of Haematology11 citations Open access
Semantic Scholar
The use of JAK inhibitors for low-risk myelofibrosis
Samah Alimam, D. Mclornan, C. Harrison
2015Expert Review of Hematology9 citations Open access
Semantic Scholar
Real World Efficacy and Safety of Momelotinib for Myelofibrosis: Evaluation of a UK-Wide Study Confirms 40% Anaemia Response Rate in a Non-Clinical Trial Cohort
Alexandros Rampotas, Elena Torre, Luke Carter-Brzezinski, Andrea Duminuco +29 more
2024Blood6 citations
Semantic Scholar
Myeloproliferative neoplasms in adolescents and young adults.
R. Amerikanou, J. Lambert, Samah Alimam
2022Baillière's Best Practice & Research: Clinical Haematology6 citations
Semantic Scholar
Essential thrombocythaemia treated with recombinant interferon: ‘real world' United Kingdom referral centre experience
Joana Desterro, D. Mclornan, N. Curto-Garcia, J. O'Sullivan +7 more
2019British Journal of Haematology6 citations Open access
Semantic Scholar
Nuvisertib (TP-3654), an Investigational Selective PIM1 Kinase Inhibitor, Showed Durable Clinical Response and Sustained Hematological Improvement in Relapsed/Refractory Myelofibrosis Patients
F. El Chaer, Lindsay A. M. Rein, J. Yuda, Kazuya Shimoda +32 more
2024Blood5 citations
Semantic Scholar
Cardiovascular risk in a contemporary cohort of patients with myeloproliferative neoplasms'.
Dipal Mehta, Samah Alimam, D. Mclornan, J. Henry +11 more
2023Current Research in Translational Medicine4 citations
Semantic Scholar
Many happy returns: machine learning to support platelet issuing and waste reduction in hospital blood banks
Joseph Farrington, Samah Alimam, Martin Utley, Ke-Zhi Li +1 more
2024arXiv.org3 citations
Semantic Scholar
Thrombocytosis and Essential Thrombocythaemia
Samah Alimam, C. Harrison
20173 citations
Semantic Scholar
Shortened telomeres in essential thrombocythemia: clinicopathological and treatment correlations
Samah Alimam, D. Mclornan, Jie Jiang, D. Radia +2 more
2017Haematologica3 citations Open access
Semantic Scholar
Sudden onset bilateral deafness as a presentation of chronic myeloid leukaemia
Samah Alimam, Mohd K. Mamat, S. Kulkarni, Tim C. P. Somervaille
2013British Journal of Haematology3 citations
Semantic Scholar
Nuvisertib, an oral investigational selective PIM1 kinase inhibitor, showed clinical responses strongly correlating with cytokine modulation in patients with relapsed/refractory myelofibrosis in the ongoing global phase I/II study
Lindsay A. M. Rein, F. El Chaer, J. Yuda, J. Scandura +38 more
2025Blood2 citations
Semantic Scholar
Adolescent and young adult patients with 'Philadelphia negative' myeloproliferative neoplasms: a real world, UK tertiary-centre study.
Dipal Mehta, Holly Theaker, Hugo Ferreira, Syeda Ahmed +6 more
2025Current Research in Translational Medicine2 citations
Semantic Scholar
Comment on McBride et al.'s ‘Can medical students use artificial intelligence to learn transfusion? Evaluating ChatGPT responses to the American Society of Hematology medical student transfusion learning objectives’
Ethan Troy-Barnes, Li Shen, Samah Alimam
2025Vox Sanguinis2 citations
Semantic Scholar
VERIFY: A randomized controlled phase 3 study of the hepcidin mimetic rusfertide (PTG-300) in patients with polycythemia vera (PV).
Aniket Bankar, Kristen M. Pettit, J. Shatzel, A. Yacoub +14 more
2024Journal of Clinical Oncology2 citations Open access
Semantic Scholar
Deep Reinforcement Learning for Managing Platelets in a Hospital Blood Bank
Joseph Farrington, Martin Utley, Samah Alimam, Wai Keong Wong +1 more
2023Blood2 citations Open access
Semantic Scholar
Single Centre Analysis of JAK2 V617F and Exon 12 Negative Idiopathic Erythrocytosis
Kushani Ediriwickrema, A. Wilson, J. O'Nions, M. Sekhar +5 more
2021Blood2 citations Open access
Semantic Scholar
Molecular, Epigenetic and Gene Expression Profiling of Triple Negative Essential Thrombocythaemia
Samah Alimam, William Villiers, R. Dillon, M. Simpson +6 more
2019Blood2 citations Open access
Semantic Scholar
Real‐world treatment patterns and outcomes in accelerated and blast‐phase myeloproliferative neoplasms: Insights from a large multi‐centre cohort analysis in the United Kingdom
A. Rampotas, Gabriel Naylor‐Layland, Claire Brown, Ahmad Alabdulkarim +31 more
2026British Journal of Haematology1 citations Open access
Semantic Scholar
Cytokine Modulation Correlates Strongly with Symptom Improvement in Patients with Myelofibrosis Treated with Nuvisertib (TP-3654), an Investigational Selective PIM1 Kinase Inhibitor
Lindsay A. M. Rein, F. El Chaer, J. Yuda, Kazuya Shimoda +32 more
2024Blood1 citations
Semantic Scholar
Attenuated Immune Responses to the Annual Influenza A Vaccine in Patients with Myeloproliferative Neoplasms
Samah Alimam, Jessica A Timms, R. Dillon, T. Mare +5 more
2019Blood1 citations Open access
Semantic Scholar
Real‐world outcomes of triplet therapy with gilteritinib, azacitidine and venetoclax in FMS‐like tyrosine kinase 3 (FLT3)‐mutated relapsed/refractory acute myeloid leukaemia: A UK single‐centre experience
W. Chan, Hannah Al-Yousuf, H. Lam, S. Leong +16 more
2026British Journal of Haematology0 citations Open access
Semantic Scholar
Accuracy of Diagnosis in Myeloproliferative Neoplasms With Splanchnic Vein Thrombosis (MPN‐SVT)
Bharath Ram Sreedhar, H. Ryou, Aoife O'Riordan, R. Hargreaves +7 more
2026American journal of hematology/oncology0 citations
Semantic Scholar
Changes in disease responses after discontinution of tyrosine kinase inhibitors (TKI) for pregnancy in established chronic myeloid leukaemia (CML): Evidence for the basis of advice for women of child-bearing age
J. Chan, H. Robertson, Afzal Khan, Samah Alimam +19 more
2025Blood0 citations
Semantic Scholar
Contemporary patient blood management in abnormally invasive placenta at a tertiary centre, with a focus on the role of the transfusion practitioner
Ethan Troy-Barnes, Melat Rone, Madeleine Daly, Lia Estrada +7 more
2025Vox Sanguinis0 citations
Semantic Scholar
Myelodysplastic/myeloproliferative overlap neoplasms: Clinicopathological features, treatment strategies, and outcomes — a UK multicentre cohort Study
Ahmad Alabdulkarim, M. Luong, Yu-Hung Wang, Elena Torre +22 more
2025Blood0 citations
Semantic Scholar
Immunoglobulin Replacement Therapy (IgRT) for the Treatment of Haematological Malignancy Associated Secondary Immunodeficiency (HM-SID) - a Large UK Tertiary Centre Experience
Z. Soe, Ahmed Eldarwi, Ethan Troy-Barnes, R. Patel +3 more
2024Blood0 citations
Semantic Scholar
Mympnvoice - a Novel Smartphone App for Monitoring Patient Reported Outcomes and Biometric Data in Patients with Myeloproliferative Neoplasms
Patrick Harrington, K. Summers, Andrea Preston, D. Street +15 more
2024Blood0 citations
Semantic Scholar
Real World, Single-Centre Experience of Pregnancy in Patients with Philadelphia Negative Myeloproliferative Neoplasms
Holly Theaker, Jonathan Lambert, D. Mclornan, Andrew J. Wilson +3 more
2023Blood0 citations Open access
Semantic Scholar
A Real World, Single-Centre Study of Young Adult Patients with Philadelphia Negative Myeloproliferative Neoplasms
Dipal Mehta, Holly Theaker, D. Mclornan, J. Lambert +5 more
2023Blood0 citations Open access
Semantic Scholar
Blood Groups, Blood Components and Alternatives to Transfusion
Samah Alimam, K. Pendry, M. Murphy
2018Scott-Brown’s Otorhinolaryngology Head and Neck Surgery0 citations
Semantic Scholar
Longitudinal Mutational Analysis in Hydroxycarbamide-Resistant/Intolerant Essential Thrombocythemia Treated on the Majic-ET Study
Jennifer O'Sullivan, A. Hamblin, A. Panchal, C. Yap +10 more
2018Blood0 citations
Semantic Scholar
Is there a role for pomalidomide in the treatment of myelofibrosis?
Samah Alimam, C. Harrison
20160 citations
Semantic Scholar
Pregnancy Outcomes in Patients with Myeloproliferative Neoplasms in the United Kingdom
Samah Alimam, L. Chappell, M. Knight, S. Bewley +3 more
20150 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Harrison×15
Invite
C. Harrison — researcher profile on SciRah
D. Mclornan×14
Invite
D. Mclornan — researcher profile on SciRah
D. Radia×6
Invite
D. Radia — researcher profile on SciRah
Andrew J. Wilson×6
Invite
Andrew J. Wilson — researcher profile on SciRah

×5

Invite

S. Kordasti — researcher profile on SciRah

Invite

A. Mead — researcher profile on SciRah

Invite

A. Panchal — researcher profile on SciRah

Invite

Sonia Fox — researcher profile on SciRah

Invite

M. McMullin — researcher profile on SciRah

Invite

R. Dillon — researcher profile on SciRah

Invite

C. Woodley — researcher profile on SciRah

Claire N. Harrison×4

Invite

Claire N. Harrison — researcher profile on SciRah